CHRS
Coherus BioSciences Inc
Price:  
0.90 
USD
Volume:  
1,222,663.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CHRS EV/EBITDA

-835.8%
Upside

As of 2025-07-16, the EV/EBITDA ratio of Coherus BioSciences Inc (CHRS) is -3.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CHRS's latest enterprise value is 316.85 mil USD. CHRS's TTM EBITDA according to its financial statements is -102.37 mil USD. Dividing these 2 quantities gives us the above CHRS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.1x - 14.2x 12.2x
Forward P/E multiples 14.9x - 27.9x 20.9x
Fair Price (10.79) - (0.30) (6.62)
Upside -1298.6% - -133.1% -835.8%
0.90 USD
Stock Price
(6.62) USD
Fair Price

CHRS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-15 -3.04
2025-07-14 -3.15
2025-07-11 -3.07
2025-07-10 -3.06
2025-07-09 -3.06
2025-07-08 -3.00
2025-07-07 -2.92
2025-07-03 -2.99
2025-07-02 -2.98
2025-07-01 -2.94
2025-06-30 -2.90
2025-06-27 -2.92
2025-06-26 -2.91
2025-06-25 -2.89
2025-06-24 -2.95
2025-06-23 -2.90
2025-06-20 -2.92
2025-06-18 -2.95
2025-06-17 -2.93
2025-06-16 -2.97
2025-06-13 -2.94
2025-06-12 -2.97
2025-06-11 -2.99
2025-06-10 -2.99
2025-06-09 -3.04
2025-06-06 -3.02
2025-06-05 -2.99
2025-06-04 -2.98
2025-06-03 -2.96
2025-06-02 -2.94
2025-05-30 -2.96
2025-05-29 -2.98
2025-05-28 -2.98
2025-05-27 -2.96
2025-05-23 -2.93
2025-05-22 -2.95
2025-05-21 -2.95
2025-05-20 -3.00
2025-05-19 -2.98
2025-05-16 -2.94
2025-05-15 -2.95
2025-05-14 -2.97
2025-05-13 -3.01
2025-05-12 -3.23
2025-05-09 -3.17
2025-05-08 -3.20
2025-05-07 -3.15
2025-05-06 -3.13
2025-05-05 -3.23
2025-05-02 -3.32